AHNS指南系列:局部晚期或不可切除头颈部鳞癌的治疗原则
本文为美国头颈学会教育委员会「你了解你的指南吗」系列文章,综述局部晚期头颈部鳞状细胞癌的治疗指南,涵盖放疗、化疗及免疫治疗药物的近期应用。讨论范围限于口腔、口咽、下咽和喉部癌,且多数内容适用于HPV阴性口咽癌,因HPV阳性口咽癌自然史、预后及分期标准不同。
要点
- 指南涵盖局部晚期头颈部鳞癌的放疗、化疗及免疫治疗原则
- 讨论范围限于口腔、口咽、下咽和喉部癌
- 多数内容适用于HPV阴性口咽癌,HPV阳性者管理不同
核心结论
- 局部晚期或不可切除头颈部鳞癌的治疗需综合放疗、化疗及免疫治疗。
研究设计与样本
- 美国头颈学会教育委员会发起的指南解读系列文章,评述现有治疗指南。
主要发现
- 文章评述了放疗、化疗及免疫治疗药物在局部晚期头颈部鳞癌中的关键作用。
- 讨论限于口腔、口咽、下咽和喉部癌,不涉及鼻咽或鼻窦癌。
- 多数内容适用于HPV阴性口咽癌,HPV阳性口咽癌自然史、预后及分期标准不同。
临床怎么用
- 临床可参考本指南原则管理局部晚期或不可切除的口腔、口咽、下咽及喉部鳞癌。
- 对HPV阳性口咽癌需注意其与HPV阴性者不同的自然史、预后及分期标准。
- 鼻咽癌和鼻窦癌的诊断与管理不在本文范围,需参考其他指南章节。
局限性
- 文章未涵盖鼻咽癌和鼻窦癌,这些主题在其他指南章节中讨论。
- 多数内容仅适用于HPV阴性口咽癌,对HPV阳性者需区别对待。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This article is a continuation of the "Do You Know Your Guidelines" series, initiated by the Education committee of the American Head and Neck Society. Treatment guidelines for advanced head and neck squamous cell carcinoma are reviewed here, including the critical roles of radiotherapy, chemotherapy, and the recent application of immunotherapy agents. We will be limiting this discussion to include cancers of the oral cavity, oropharynx, hypopharynx, and larynx. It should be noted that much of the article pertains to human papillomavirus (HPV)-negative oropharyngeal cancer where applicable, as HPV-positive oropharyngeal squamous cell carcinoma carries a different natural history, different prognosis, and now different staging criteria. Additionally, the article will not include information on nasopharyngeal or sinus cancers, as these latter topics are covered in separate "Do you know your guidelines?" installments and these diagnoses carry somewhat different approaches to diagnosis and management that diverge from the focus of this article.
引用
- Fulcher CD, Haigentz M, Ow TJ, et al. AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma. Head Neck. 2017. PMID: 29171929. doi:10.1002/hed.25025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。